Financial Report Analysis

Executive Summary For the third quarter of fiscal year 2025, Airship AI Holdings Inc. demonstrated significant growth driven primarily by a substantial increase in revenue and improved operational metrics. The company’s revenue surged by approximately 310% compared to the same…

Executive Summary Veea Inc reported its third quarter of fiscal year 2025 with significant financial shifts. The company experienced a substantial reduction in net loss, decreasing by approximately 28.8% quarter-over-quarter from $46.1 million in Q3 FY2024 to $33.3 million in…

Executive Summary MiNK Therapeutics Inc (INKT) reported its fiscal third quarter of 2025, demonstrating significant operational and financial developments. The company’s net loss decreased by approximately 42.4% compared to the previous quarter, reflecting improved cost management and strategic adjustments. Despite…

Executive Summary VOR Biopharma Inc., a clinical-stage biotechnology company focused on autoimmune therapies, reported its financial results for the third quarter of fiscal year 2025. The company experienced a significant increase in net loss, primarily driven by substantial changes in…

Executive Summary OS Therapies Inc. (OSTX) reported its financial results for the third quarter of fiscal year 2025, demonstrating significant improvement in its net loss figures. The company’s net loss decreased by approximately 43.4% from the previous quarter, reflecting progress…

Executive Summary Atlantic International Corp. (ATLN) reported its fiscal third quarter of 2025, demonstrating a 4.4% year-over-year increase in total revenue, driven primarily by growth in its staffing services segment. Despite a significant net loss, the company maintains a strong…

Executive Summary In the third quarter of fiscal year 2025, Nexalin Technology Inc (NASDAQ: NXL) reported a significant increase in revenue, rising from USD 12.7 million in the same period last year to USD 18.1 million, representing a 49.4% year-over-year…

Executive Summary Qualigen Therapeutics reported a net loss of $2.04 million for the third quarter of fiscal year 2025, representing a 14.7% decrease from the net loss of $2.39 million in the same period last year. The company’s cash position…

Executive Summary Predictive Oncology Inc. (NASDAQ: POAI) reported its fiscal third quarter of 2025, demonstrating a significant reduction in net loss compared to the same period last year. The company’s net loss from continuing operations decreased by approximately 92.4%, from…

Executive Summary In the third quarter of fiscal year 2025, Mersana Therapeutics Inc reported a net loss of $7.5 million, representing a 34.5% decrease compared to the $11.5 million net loss in the same period last year. The company’s total…

Executive Summary This quarterly report for ReShape Lifesciences Inc. highlights significant financial challenges, with revenue declining sharply by 85% compared to the previous year and a substantial net loss of $8.595 million. The company’s liquidity position remains relatively stable with…

Executive Summary Ryvyl Inc (RVYL) reported its fiscal third quarter of 2025 with a net loss of $13.1 million, representing a 74.7% decrease compared to a net loss of $51.7 million in the same period last year. Revenue remained relatively…

Executive Summary Forte Biosciences Inc (NASDAQ: FBRX) reported its third quarter fiscal year 2025 financial results, showing a significant reduction in net loss compared to the same period last year. The company’s net loss decreased by 50.2%, from $8.39 million…

Executive Summary Lyra Therapeutics Inc. reported its financial results for the third quarter of fiscal year 2025, demonstrating a significant reduction in net loss compared to the prior quarter. The net loss decreased by approximately 49.7%, from $11.87 million in…

Executive Summary PEDEVCO Inc (NYSE: PED) reported its third quarter of fiscal year 2025, demonstrating a significant year-over-year revenue growth of 26%, driven by increased oil and gas sales. The company’s cash and cash equivalents surged to $10.9 million, reflecting…

Executive Summary In the third quarter of fiscal year 2025, VerifyMe Inc (NASDAQ: VRME) reported a total revenue of $5.03 million, representing a 4.4% increase compared to $4.83 million in the same period last year. The company’s net loss widened…

Executive Summary Jones Soda Co reported its third quarter of fiscal year 2025 with notable declines in revenue and net income compared to the previous year, reflecting ongoing challenges in market penetration and cost management. Despite a revenue decrease of…

Executive Summary TAITRON COMPONENTS INC, trading under the ticker TAIT on NASDAQ, reported its fiscal third quarter of 2025. The company experienced a significant decline in revenue, dropping by 61.7% compared to the same period last year, primarily due to…

Executive Summary Trio-Tech International (TRT) reported its fiscal third quarter of 2025 with significant revenue decline and net loss compared to the same period last year. Revenue decreased from $10.398 million in Q3 FY2024 to $7.384 million in Q3 FY2025,…

Executive Summary GT Biopharma Inc (NASDAQ: GTBP) reported its third quarter financial results for FY2025, showing a significant reduction in net loss compared to the same period last year. The company’s net loss decreased by approximately 25.4%, from $4.3 million…

Executive Summary UAVS, trading under the ticker UAVS, reported its fiscal third quarter for 2025, showing a significant decline in revenue compared to the same period last year. The revenue dropped by 40.0%, from USD 3.28 million in 2024Q3 to…

Key Metrics Metric Q3 FY2025 Q3 FY2024 Change Revenue (USD Thousands) 22,267 20,174 10.4% Increase Net Income (USD Thousands) -3,253 554 Decreased by 738.4% Gross Profit (USD Thousands) 2,380 1,831 30.0% Increase Operating Cash Flow (USD Thousands) -2,974 -1,042 Increased…

Executive Summary CID Holdco, Inc. (Ticker: DAIC) reported its fiscal third quarter of 2025 with a remarkable surge in revenue, increasing by approximately 347% compared to the same period last year. This substantial growth reflects the company’s successful expansion and…

Executive Summary In the third quarter of fiscal year 2025, New Era Helium Inc (NEHC) reported a significant decline in revenue, dropping by 16% from the previous year, alongside a substantial net loss of $5.78 million. The company’s liquidity position…

Executive Summary Rain Enhancement Technologies Holdco Inc reported a significant decline in net income for Q3 FY2025, with a net loss of $2.2 million, representing a 62.2% decrease compared to the same period last year. The company’s revenue remained zero,…